As of 2024-12-14, the Intrinsic Value of Klingelnberg AG (KLIN.SW) is
33.68 CHF. This KLIN.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 14.15 CHF, the upside of Klingelnberg AG is
138.00%.
The range of the Intrinsic Value is 24.30 - 52.84 CHF
33.68 CHF
Intrinsic Value
KLIN.SW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
24.30 - 52.84 |
33.68 |
138.0% |
| DCF (Growth 10y) |
32.37 - 67.80 |
44.05 |
211.3% |
| DCF (EBITDA 5y) |
14.90 - 26.54 |
20.94 |
48.0% |
| DCF (EBITDA 10y) |
20.47 - 33.58 |
26.95 |
90.4% |
| Fair Value |
7.61 - 7.61 |
7.61 |
-46.21% |
| P/E |
14.71 - 27.69 |
21.05 |
48.8% |
| EV/EBITDA |
5.33 - 29.92 |
17.76 |
25.5% |
| EPV |
48.58 - 75.71 |
62.15 |
339.2% |
| DDM - Stable |
16.91 - 51.73 |
34.32 |
142.5% |
| DDM - Multi |
32.01 - 76.72 |
45.23 |
219.6% |
KLIN.SW Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
125.09 |
| Beta |
0.27 |
| Outstanding shares (mil) |
8.84 |
| Enterprise Value (mil) |
166.73 |
| Market risk premium |
5.10% |
| Cost of Equity |
4.98% |
| Cost of Debt |
5.00% |
| WACC |
4.79% |